Navigation Links
BodySculpt(TM) Leads FDA Approval of BodyTite(TM) with Largest Number of Documented Study Cases
Date:9/16/2009

NEW YORK, Sept. 16 /PRNewswire/ -- The plastic surgeons at BodySculpt(TM) are revolutionizing the latest techniques in liposuction -- one radio-frequency wave at a time. Since being selected by Invasix to head the FDA approval studies of BodyTite(TM), BodySculpt(TM) has lead the industry in its number of case studies and field research. The latest device in body-contouring procedures, BodyTite(TM) utilizes radio-frequency assisted liposuction (RFAL) technology. With the direction of board certified BodySculpt(TM) Surgical Director Dr. Christopher Chia BodySculpt(TM) is the first team of surgeons in the New York area to use BodyTite(TM) and is the leading authority in RFAL and its introduction to the world of plastic surgery.

BodyTite(TM) is the most compact and ergonomic, energy-assisted liposuction device in the world, in addition to being powerful, minimally invasive and safe. BodyTite(TM) liposuction procedures not only produce successful fat removal with less downtime, but also improve patient safety and comfort.

After conducting several case studies on women with postpartum body insecurities, the plastic surgeons at BodySculpt(TM) have even deemed it as the "virtual no scar tummy-tuck". The RFAL technology induces simultaneous tissue liquefaction, blood vessel coagulation, and heating of the skin, which results in optimal soft tissue contraction and skin tightening. This makes the procedure ideal for postpartum patients or others with compromised skin laxity, such as those who have just experienced extreme weight loss.

Having conducted the largest number of study cases of the procedure in the US, the impressive findings of the doctors at BodySculpt(TM) will aide in determining industry-wide effectiveness and safety standards of BodyTite(TM) once approved by the FDA. Results, reactions, and conclusions thus far have been extremely positive and successful- great news for the FDA
'/>"/>

SOURCE BodySculpt
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. San Ramon HR Firm Leads Response to New Cal/OSHA ATD Law
2. Genetic Research Leads to New Discovery in Understanding Rare Neurological Disorder
3. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
4. Pharmaleads Lead Candidate for Pain, PL37, Enters Phase I
5. Discovery Leads to Earlier Diagnosis of Type 1 Diabetes
6. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
9. Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
10. ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis
11. WorldHeart Receives US Clinical Study Approval for the Levacor(TM) VAD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 Research ... addition of the "Investigation Report on China,s ... Developed by AstraZeneca plc, quetiapine (under ... drug for the treatment of schizophrenia. Approved by ... listed in the Catalogue of Drugs for the ...
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... Novartis, ranibizumab was approved by CFDA to treat wet ... Lucentis, a product of Novartis, is available in the ... self- developed drug for the treatment of wet AMD ...
(Date:8/28/2015)... Perrigo Company plc ("Perrigo") (NYSE: PRGO ... (NASDAQ: MYL ) shareholder vote regarding its planned ... of Mylan,s offer to Perrigo shareholders have always been, ... careful reflection of the value available to Perrigo shareholders, ... Mylan has allowed its shareholders to consider," said ...
Breaking Medicine Technology:China Quetiapine Market Investigation Report 2010-2019 2Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... SAN MARINO, Calif. , July 6 ... of targeted genetic medicine, received a notice of allowance ... leading tumor-targeted gene delivery platform. The issuance of this ... follows on the heels of two major patent issuances ...
... N.J. , July 6 Nephros, Inc. (OTC Bulletin ... for therapeutic applications, infection control, and water purification, today reported that ... a standard component of its MRO portable reverse osmosis water treatment ... , ...
Cached Medicine Technology:Small, Smart, Stealth Nanoparticles Seek-and-Destroy Metastatic Cancers, as Epeius Biotechnologies Advances its Intellectual Property Estate With Additional U.S. Patents 2Small, Smart, Stealth Nanoparticles Seek-and-Destroy Metastatic Cancers, as Epeius Biotechnologies Advances its Intellectual Property Estate With Additional U.S. Patents 3Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 2Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 3Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 4Nephros and AmeriWater Announce Dual Stage Ultrafilters to be a Standard Component of MRO Series Water Treatment Systems 5
(Date:8/30/2015)... Auckland, NZ (PRWEB) , ... August 30, 2015 ... ... enterprise collaboration across platforms and devices, today announced it is a Silver Sponsor ... 1, 2015 at Sky City Convention Centre in Auckland, NZ. Throughout the event, ...
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... InHealth Media. Nutritional Products International and InHealth media is a global sales and ... , “We are extremely pleased to continue our business relationship with Mr. Reid Eckert, ...
(Date:8/29/2015)... ... August 30, 2015 , ... On September 30, 2015, the ... of the 10 regionally accredited Maricopa Community Colleges , will be hosting a ... students pursuing employment information and opportunities. , The Expo has expanded to much more ...
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible by ... of patients, according to a newly published report. Surviving Mesothelioma has more on ... , The authors of the new paper focus on several types of ...
(Date:8/29/2015)... , ... August 29, 2015 , ... ... angina, chronic obstructive pulmonary disease (including emphysema), or asthma, are at higher risk ... angina, previous heart attack, heart failure or heart-rhythm problems (arrhythmia or irregular heartbeat) ...
Breaking Medicine News(10 mins):Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:Heart Fit Clinic Sounds the Alarm on Forest Fire Smoke and Chronic Heart Disease in Calgary Area 2
... issue of Technology & Innovation, Proceedings of the ... bright future and enormous need for stem cell therapeutics ... and deadly diseases. http://www.ingentaconnect.com/content/cog/ti/2011/00000013/00000001 ... cell replacement" procedures to restructure damaged organs, tissues and ...
... ICU , Intensive care units are facing staffing ... A recent study, conducted by physicians from Beth Israel ... York, NY, studying 590 daytime admissions in two intensive ... address these staff shortages. In the study, no ...
... 8 to 18 consume an average of 13 hours of ... their white counterparts, according to a Northwestern University report, the ... by race and ethnicity. "In the past decade, the ... doubled for blacks and quadrupled for Hispanics," says Northwestern Professor ...
... researcher in the University of Cincinnati (UC) Department of ... from the Emergency Medicine Foundation to study the implementation ... (ED). The award will support the work of ... of Medicine. Ward has spent the past year focusing ...
... This release is available in French . Montreal, ... needs to be decriminalized, according to a new report published in ... and University of Windsor researchers, the study calls for sweeping changes ... "We must not only change our laws, we must also revamp ...
... Houston environmental engineer will test parts of Galveston Bay ... officials determine the best way to handle those pollutants., ... through a Texas Commission on Environmental Quality (TCEQ) grant ... last fall for similar research in the Houston Ship ...
Cached Medicine News:Health News:The future of stem cell applications challenging, bright 2Health News:Chest journal news briefs -- June 2011 issue 2Health News:Study: Stark differences in media use between minority and white youth 2Health News:Study: Stark differences in media use between minority and white youth 3Health News:Study: Stark differences in media use between minority and white youth 4Health News:Using simulation to model the implementation of electronic health records 2Health News:Dangerous and under the radar 2Health News:Dangerous and under the radar 3Health News:University of Houston researcher receives grant to study water pollutants 2
... anyone using the Farnsworth D15, L'Anthony desaturated test ... patients cannot avoid touching the color disks with ... Further, the disks are very easy to loose.,We ... in order to solve these problems. We have ...
... Farnsworth Dichotomous testing sets are designed ... The Farnsworth D15 test is used to ... Normal. The L'Anthony Desaturated test is much ... mild deficiency from Normal. Both of ...
... The NOW Strep A test is as easy ... minutes to results. Increase patient satisfaction with rapid ... can treat your patient immediately with the appropriate ... , ,Intended Use: ,The NOW® Strep A Test ...
12 mm single use, reloadable laparoscopic linear stapler with titanium staples....
Medicine Products: